There is no additional benefit wearing the patch longer than 8 hours
Other compounds like GHRP-2 and GHRP-6 might be administered 13 times daily, with some protocols emphasizing spacing them out from meals to maximize efficacy
Liang, Q., Du, L., Zhang, R., Kang, W., & Ge, S
We analyzed 34 randomized clinical trials comparing: Continuous positive airway pressure (CPAP) GLP-1 receptor agonists No active intervention Here is what the evidence shows: CPAP remains the most effective therapy for reducing AHI GLP-1 receptor agonists produce clinically meaningful BMI and HbA1c reductions Blood pressure effects were inconsistent Respiratory and metabolic domains behave differently This is not a competition between CPAP and GLP-1 therapy
Both these ingredients are derived from amino acids and play key roles in supporting the body's energy production processes